|
시장보고서
상품코드
1940972
척수자극기 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2033년)Spinal Cord Stimulators Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
세계의 척수자극기(SCS) 시장은 의료 제공업체가 만성 통증 관리를 위한 선진적인 해결책을 점점 더 요구하고 있는 가운데 견조한 성장을 이루고 있습니다. 척수자극기는 척수에 전기 자극을 전달하도록 설계된 임베디드 의료기기로, 척추 수술 후 통증 증후군(FBSS), 추간판 변성증(DDD), 복합성 국소 통증 증후군(CRPS), 기타 신경 질환 등 지속적인 통증 상태 관리에 환자를 지원합니다. 시장 규모는 2026년 38억 달러에서 2033년까지 65억 달러에 달할 전망이고, CAGR 7.80%로 확대될 것으로 예측되고 있으며, 세계적으로 신경조절 요법의 중요성이 높아지고 있음을 보여주고 있습니다.
시장 인사이트
척수자극기 시장은 기술 혁신, 환자 의식 증가, 병원, 전문 클리닉, 외래수술센터(ASC)의 도입 확대에 견인되고 있습니다. 충전식 및 비충전식 장치, 무선 시스템, MRI 지원 자극기, 폐루프 신경 조절 기술 등의 혁신으로 환자의 편안함과 임상 성과가 현저히 향상되었습니다.
게다가 연구개발 활동을 통해 척수자극기의 적용 범위는 기존의 만성 통증 관리를 넘어 확대를 계속하고 있으며, 이러한 장치는 현대의료에서 다용도 솔루션으로서의 지위를 확립하고 있습니다. 의료 인프라가 정비된 지역에서는 특히 성장이 현저하지만, 신흥 시장에서는 의료 접근의 향상 및 환자의 경제적 부담 경감에 의해 도입이 확대되고 있습니다.
시장 성장 촉진요인
척수 자극기 시장의 급속한 성장에는 몇 가지 요인이 기여합니다.
- 만성 통증 증가 : FBSS(척추 수술 후 증후군), DDD(추간판 변성증), CRPS(복합성 국소 통증 증후군) 등 지속적인 통증 상태가 효과적이고 장기적인 치료법에 대한 수요를 견인하고 있습니다.
- 기술적 진보 : 현대의 자극 장치는 충전식 배터리, MRI 대응, 무선 통신, 폐루프 피드백 등을 갖추고, 장치의 성능 및 환자의 치료 연속성을 향상시키고 있습니다.
- 저침습 수술 : SCS의 임베디드 기술은 침습성이 낮아지고 회복 기간 및 수술 후 합병증의 감소로 이어집니다.
- 고령화 : 노화와 관련된 척추 변성 질환이 세계적으로 증가하고 있으며 신경 조절 요법 수요 증가에 기여하고 있습니다.
- 지원 상환 정책 : 주요 지역의 유리한 상환 프레임워크는 SCS 장치의 보다 광범위한 채택을 촉진합니다.
비즈니스 기회
척수자극기 시장은 의료기기 제조업체, 의료 제공업체 및 기술 혁신자에게 큰 기회를 제공합니다. SCS 디바이스와 원격 모니터링 및 원격 의료 플랫폼의 통합은 환자 중심의 치료를 향한 새로운 길을 열고 있습니다. 연구개발 주도 제품 개발, 환자 중심 설계, 의료기관과의 제휴에 투자하는 기업은 큰 시장 점유율을 획득할 가능성이 높을 것입니다. 또한, 척수자극기를 다른 신경 조절 요법과 결합하면 추가 수익원이 생겨 임상 성과가 향상됩니다.
지역별 분석
북미는 첨단 의료 인프라, 환자의 높은 인지도, 종합적인 상환 제도에 힘입어 세계 시장을 선도하고 있습니다. 미국은 이 지역 최대의 공헌국이며, SCS 기술의 채용이 확대되고 있습니다.
유럽도 성숙 시장이며 독일, 영국, 프랑스 등의 국가들이 확립된 의료시스템과 강력한 기술 도입으로 성장을 견인하고 있습니다.
아시아태평양은 예측 기간 동안 가장 높은 성장률을 달성할 것으로 예측됩니다. 의료 접근의 급속한 개선, 노인 인구 증가, 첨단 통증 관리 요법에 대한 인식 증가가 일본, 중국, 인도 등 국가에서 수요를 뒷받침하고 있습니다.
라틴아메리카 및 중동 및 아프리카에서는 의료 인프라 정비, 만성 통증에 대한 인식이 높아지고 선진 의료 기술에 대한 투자 증가로 완만하면서도 확대할 기회가 예상됩니다.
주요 기업
세계의 척수 자극기 시장은 경쟁이 치열하며 주요 기업은 혁신, 파트너십 및 전략적 인수에 적극적으로 투자하고 있습니다.
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp.
- Stimwave Technologies
- B. Braun Melsungen AG
- Nuvectra Corporation
- Proteus Digital Health(현재는 Medtronic의 일부)
- Colombus NeuroTech
- Cyberonics(LivaNova PLC)
- Minimally Invasive Neuromodulation, Inc.
- Nexstim Oy
- Saluda Medical Pty Ltd.
- Axonics Modulation Technologies
- Biotronik SE & Co. KG
시장 세분화
제품별
- 충전식
- 비충전식
질병별
- 척추 수술 후 증후군(FBSS)
- 추간판 변성증(DDD)
- 복합성 국소 통증 증후군(CRPS)
- 거미막염
- 기타
최종 사용자별
- 병원
- 외래수술센터(ASC)
- 전문 클리닉
지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의 및 세분화
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter's Five Forces 분석
- 러시아와 우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재의 가격 및 장래 예측(2025-2033년)
- 가격 영향요인
제3장 세계의 척수자극기 시장 전망(2020-2033년)
- 세계의 척수자극기 시장 전망 : 제품별, 금액(10억 달러)(2020-2033년)
- 충전식
- 비충전식
- 세계의 척수자극기 시장 전망 : 질환별, 금액(10억 달러)(2020-2033년)
- 등 수술 실패 증후군(FBSS)
- 변성 추간판 질환(DDD)
- 복합성 국소 통증 증후군(CRPS)
- 거미막염
- 기타
- 세계의 척수자극기 시장 전망 : 최종 사용자별, 금액(10억 달러)(2020-2033년)
- 병원
- 외래수술센터(ASC)
- 전문 클리닉
- 세계의 척수자극기 시장 전망 : 지역별, 금액(10억 달러)(2020-2033년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미의 척수자극기 시장 전망(2020-2033년)
제5장 유럽의 척수자극기 시장 전망(2020-2033년)
제6장 아시아태평양의 척수자극기 시장 전망(2020-2033년)
제7장 라틴아메리카의 척수자극기 시장 전망(2020-2033년)
제8장 중동 및 아프리카의 척수자극기 시장 전망(2020-2033년)
제9장 경쟁 구도
- 기업 대 부문 히트맵
- 기업의 시장 점유율 분석(2025년)
- 경쟁 대시보드
- 기업 프로파일
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp.
- Stimwave Technologies
- B. Braun Melsungen AG
- Nuvectra Corporation
- Proteus Digital Health(현재는 Medtronic의 일부)
- Colombus NeuroTech
- Cyberonics(LivaNova PLC)
제10장 부록
AJY 26.03.03The global spinal cord stimulators (SCS) market is experiencing robust growth as healthcare providers increasingly seek advanced solutions for chronic pain management. Spinal cord stimulators are implantable medical devices designed to deliver electrical impulses to the spinal cord, helping patients manage persistent pain conditions such as Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), and other neurological disorders. The market is anticipated to grow from USD 3.8 billion in 2026 to USD 6.5 billion by 2033, at a compound annual growth rate (CAGR) of 7.80%, highlighting the growing importance of neuromodulation therapies worldwide.
Market Insights
The spinal cord stimulators market is driven by technological advancements, rising patient awareness, and increased adoption across hospitals, specialty clinics, and ambulatory surgical centers. Innovations in rechargeable and non-rechargeable devices, wireless systems, MRI-compatible stimulators, and closed-loop neuromodulation are significantly improving patient comfort and clinical outcomes.
Moreover, research and development activities continue to expand the applications of spinal cord stimulators beyond conventional chronic pain management, positioning these devices as a versatile solution in modern healthcare. Growth is especially pronounced in regions with advanced healthcare infrastructure, while emerging markets are witnessing increased adoption due to rising healthcare access and improving patient affordability.
Market Drivers
Several factors are contributing to the rapid growth of the spinal cord stimulators market:
- Increasing Prevalence of Chronic Pain: Persistent pain conditions, including FBSS, DDD, and CRPS, are driving demand for effective, long-term treatment options.
- Technological Advancements: Modern stimulators feature rechargeable batteries, MRI compatibility, wireless communication, and closed-loop feedback, enhancing device performance and patient adherence.
- Minimally Invasive Procedures: SCS implantation techniques are becoming less invasive, reducing recovery time and post-operative complications.
- Aging Population: Age-related degenerative spinal disorders are rising globally, contributing to higher demand for neuromodulation therapies.
- Supportive Reimbursement Policies: Favorable reimbursement frameworks in key regions are encouraging wider adoption of SCS devices.
Business Opportunities
The spinal cord stimulators market presents significant opportunities for medical device manufacturers, healthcare providers, and technology innovators. Integration of SCS devices with remote monitoring and telehealth platforms is opening new avenues for patient-centric care. Companies investing in research-driven product development, patient-focused designs, and collaborations with healthcare institutions are likely to capture substantial market share. Additionally, combining spinal cord stimulators with other neuromodulation therapies provides additional revenue streams and strengthens clinical outcomes.
Regional Analysis
North America leads the global market, supported by advanced healthcare infrastructure, high patient awareness, and comprehensive reimbursement coverage. The United States is the largest contributor in the region, with increasing adoption of SCS technologies.
Europe also represents a mature market, with countries such as Germany, the United Kingdom, and France driving growth due to well-established healthcare systems and strong technological adoption.
Asia Pacific is expected to achieve the highest growth rate during the forecast period. Rapidly improving healthcare access, growing geriatric populations, and rising awareness of advanced pain management therapies are fueling demand in countries including Japan, China, and India.
Latin America and the Middle East & Africa present moderate yet expanding opportunities due to healthcare infrastructure development, growing chronic pain awareness, and increasing investment in advanced medical technologies.
Key Players
The global spinal cord stimulators market is highly competitive, with leading players actively investing in innovation, partnerships, and strategic acquisitions:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp.
- Stimwave Technologies
- B. Braun Melsungen AG
- Nuvectra Corporation
- Proteus Digital Health (now part of Medtronic)
- Colombus NeuroTech
- Cyberonics (LivaNova PLC)
- Minimally Invasive Neuromodulation, Inc.
- Nexstim Oy
- Saluda Medical Pty Ltd.
- Axonics Modulation Technologies
- Biotronik SE & Co. KG
Market Segmentation
By Product
- Rechargeable
- Non-rechargeable
By Disease Indication
- Failed Back Surgery Syndrome (FBSS)
- Degenerative Disc Disease (DDD)
- Complex Regional Pain Syndrome (CRPS)
- Arachnoiditis
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Spinal Cord Stimulators Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Spinal Cord Stimulators Market Outlook, 2020-2033
- 3.1. Global Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Rechargeable
- 3.1.2. Non-rechargeable
- 3.2. Global Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 3.2.1. Failed Back Surgery Syndrome (FBSS)
- 3.2.2. Degenerative Disc Disease (DDD)
- 3.2.3. Complex Regional Pain Syndrome (CRPS)
- 3.2.4. Arachnoiditis
- 3.2.5. Others
- 3.3. Global Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.3.1. Hospitals
- 3.3.2. Ambulatory Surgical Centers
- 3.3.3. Specialty Clinics
- 3.4. Global Spinal Cord Stimulators Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Spinal Cord Stimulators Market Outlook, 2020-2033
- 4.1. North America Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Rechargeable
- 4.1.2. Non-rechargeable
- 4.2. North America Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 4.2.1. Failed Back Surgery Syndrome (FBSS)
- 4.2.2. Degenerative Disc Disease (DDD)
- 4.2.3. Complex Regional Pain Syndrome (CRPS)
- 4.2.4. Arachnoiditis
- 4.2.5. Others
- 4.3. North America Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.3.1. Hospitals
- 4.3.2. Ambulatory Surgical Centers
- 4.3.3. Specialty Clinics
- 4.4. North America Spinal Cord Stimulators Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 4.4.2. U.S. Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 4.4.3. U.S. Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 4.4.4. Canada Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 4.4.5. Canada Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 4.4.6. Canada Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Spinal Cord Stimulators Market Outlook, 2020-2033
- 5.1. Europe Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Rechargeable
- 5.1.2. Non-rechargeable
- 5.2. Europe Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 5.2.1. Failed Back Surgery Syndrome (FBSS)
- 5.2.2. Degenerative Disc Disease (DDD)
- 5.2.3. Complex Regional Pain Syndrome (CRPS)
- 5.2.4. Arachnoiditis
- 5.2.5. Others
- 5.3. Europe Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.3.1. Hospitals
- 5.3.2. Ambulatory Surgical Centers
- 5.3.3. Specialty Clinics
- 5.4. Europe Spinal Cord Stimulators Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.2. Germany Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.3. Germany Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.4. Italy Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.5. Italy Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.6. Italy Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.7. France Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.8. France Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.9. France Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.10. U.K. Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.11. U.K. Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.12. U.K. Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.13. Spain Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.14. Spain Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.15. Spain Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.16. Russia Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.17. Russia Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.18. Russia Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.4.19. Rest of Europe Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 5.4.20. Rest of Europe Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 5.4.21. Rest of Europe Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Spinal Cord Stimulators Market Outlook, 2020-2033
- 6.1. Asia Pacific Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Rechargeable
- 6.1.2. Non-rechargeable
- 6.2. Asia Pacific Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 6.2.1. Failed Back Surgery Syndrome (FBSS)
- 6.2.2. Degenerative Disc Disease (DDD)
- 6.2.3. Complex Regional Pain Syndrome (CRPS)
- 6.2.4. Arachnoiditis
- 6.2.5. Others
- 6.3. Asia Pacific Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.3.1. Hospitals
- 6.3.2. Ambulatory Surgical Centers
- 6.3.3. Specialty Clinics
- 6.4. Asia Pacific Spinal Cord Stimulators Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.2. China Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.3. China Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.4.4. Japan Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.5. Japan Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.6. Japan Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.4.7. South Korea Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.8. South Korea Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.9. South Korea Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.4.10. India Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.11. India Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.12. India Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.4.13. Southeast Asia Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.14. Southeast Asia Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.15. Southeast Asia Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.4.16. Rest of SAO Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 6.4.17. Rest of SAO Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 6.4.18. Rest of SAO Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Spinal Cord Stimulators Market Outlook, 2020-2033
- 7.1. Latin America Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Rechargeable
- 7.1.2. Non-rechargeable
- 7.2. Latin America Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 7.2.1. Failed Back Surgery Syndrome (FBSS)
- 7.2.2. Degenerative Disc Disease (DDD)
- 7.2.3. Complex Regional Pain Syndrome (CRPS)
- 7.2.4. Arachnoiditis
- 7.2.5. Others
- 7.3. Latin America Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.3.1. Hospitals
- 7.3.2. Ambulatory Surgical Centers
- 7.3.3. Specialty Clinics
- 7.4. Latin America Spinal Cord Stimulators Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 7.4.2. Brazil Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 7.4.3. Brazil Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 7.4.4. Mexico Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 7.4.5. Mexico Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 7.4.6. Mexico Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 7.4.7. Argentina Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 7.4.8. Argentina Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 7.4.9. Argentina Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 7.4.10. Rest of LATAM Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 7.4.11. Rest of LATAM Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 7.4.12. Rest of LATAM Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Spinal Cord Stimulators Market Outlook, 2020-2033
- 8.1. Middle East & Africa Spinal Cord Stimulators Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Rechargeable
- 8.1.2. Non-rechargeable
- 8.2. Middle East & Africa Spinal Cord Stimulators Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
- 8.2.1. Failed Back Surgery Syndrome (FBSS)
- 8.2.2. Degenerative Disc Disease (DDD)
- 8.2.3. Complex Regional Pain Syndrome (CRPS)
- 8.2.4. Arachnoiditis
- 8.2.5. Others
- 8.3. Middle East & Africa Spinal Cord Stimulators Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.3.1. Hospitals
- 8.3.2. Ambulatory Surgical Centers
- 8.3.3. Specialty Clinics
- 8.4. Middle East & Africa Spinal Cord Stimulators Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 8.4.2. GCC Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 8.4.3. GCC Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 8.4.4. South Africa Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 8.4.5. South Africa Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 8.4.6. South Africa Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 8.4.7. Egypt Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 8.4.8. Egypt Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 8.4.9. Egypt Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 8.4.10. Nigeria Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 8.4.11. Nigeria Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 8.4.12. Nigeria Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 8.4.13. Rest of Middle East Spinal Cord Stimulators Market Outlook, by Product, 2020-2033
- 8.4.14. Rest of Middle East Spinal Cord Stimulators Market Outlook, by Disease Indication, 2020-2033
- 8.4.15. Rest of Middle East Spinal Cord Stimulators Market Outlook, by End User, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Medtronic plc
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Abbott Laboratories
- 9.4.3. Boston Scientific Corporation
- 9.4.4. Nevro Corp.
- 9.4.5. Stimwave Technologies
- 9.4.6. B. Braun Melsungen AG
- 9.4.7. Nuvectra Corporation
- 9.4.8. Proteus Digital Health (now part of Medtronic)
- 9.4.9. Colombus NeuroTech
- 9.4.10. Cyberonics (LivaNova PLC)
- 9.4.1. Medtronic plc
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
